Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases

NCT01823003 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis

Interventions

RADIATION: 34 Gy in a single fraction
RADIATION: 54Gy 18Gy/fr. x 3 fractions
RADIATION: 60Gy (12 x 5 fr.s)
RADIATION: 60Gy (7.5Gy x 8fr.)

Sponsor

Institut Català d'Oncologia